In the last years, it has been shown that differential PD1 expression levels on CD8+ T cells exist in HCC patients, and this allows for a phenotypic and functional classification of the tumor-infiltrating CD8+ T cells. This evidence concerns the gene CD8A and hepatocellular carcinoma.